SCHEMBL6016702

SCHEMBL6016702

COC(=O)Cc1n[nH]c2cc(Nc3ncc(F)c(Nc4ccc5c(c4)OCCO5)n3)ccc12

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 16/20 0.59
EGFR P00533 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016257 1.00 SYK (0.59) SYKEGFR
SCHEMBL6016285 0.94 SYK (0.59) SYKEGFR
SCHEMBL6016415 0.94 SYK (0.59) SYKEGFR
SCHEMBL6016351 0.90 SYK (0.64) SYKEGFR
SCHEMBL6016543 0.87 SYK (0.55) SYKEGFR
SCHEMBL6016654 0.86 SYK (0.64) SYKEGFR
SCHEMBL6016383 0.84 SYK (0.59) SYK
SCHEMBL6016125 0.84 SYK (0.59) SYK
SCHEMBL6016599 0.84 SYK (0.62) SYKEGFR
SCHEMBL6016642 0.84 SYK (0.64) SYKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed